2021
DOI: 10.1016/j.mcat.2021.111404
|View full text |Cite
|
Sign up to set email alerts
|

A robust and stereocomplementary panel of ene-reductase variants for gram-scale asymmetric hydrogenation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
21
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 19 publications
(21 citation statements)
references
References 52 publications
0
21
0
Order By: Relevance
“…The demonstrated continuous Hyd1 stability over time (Supporting Information, Figure S12) is an important performance benchmark for potential commercial applications, particularly in flow [37] . Furthermore, this application is likely to extend to Ts OYE variants, which have demonstrated broad substrate acceptance, are robust in harsh conditions, and can switch enantioselectivity [38] …”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The demonstrated continuous Hyd1 stability over time (Supporting Information, Figure S12) is an important performance benchmark for potential commercial applications, particularly in flow [37] . Furthermore, this application is likely to extend to Ts OYE variants, which have demonstrated broad substrate acceptance, are robust in harsh conditions, and can switch enantioselectivity [38] …”
Section: Methodsmentioning
confidence: 99%
“…Zuschriften cation is likely to extend to TsOYE variants, which have demonstrated broad substrate acceptance, are robust in harsh conditions, and can switch enantioselectivity. [38] We extended this system to two commercially available ene-reductases, ENE-103 and ENE-107 (Johnson Matthey), which are typically sold as a kit with GDH and formate dehydrogenase for NAD(P)H recycling. The alkene reductions demonstrated were dimethyl itaconate (3) reduction to dimethyl (R)-methyl succinate (4) by ENE-103 and 4-phenyl-3-buten-2-one (5) reduction to 4-phenyl-2-butanone (6) by ENE-107 (Table 2), using the same protocols established for TsOYE.…”
Section: Angewandte Chemiementioning
confidence: 99%
“…Ene-reductases (EREDs) from the old yellow enzyme (OYE) family are flavin-dependent enzymes that catalyze the chemo-and stereo-selective asymmetric reduction of electronically activated carbon-carbon double bonds [25,27,[60][61][62], as depicted in Scheme 8. Several examples can be found in literature illustrating the use of whole cells-catalyzed cascades coupling BVMO and ERED activities.…”
Section: Multi-step Reactions Including Ered/bvmo Activity Catalyzed ...mentioning
confidence: 99%
“…Ene-reductases (EREDs) from the old yellow enzyme (OYE) family are flavin-dependent enzymes that catalyze the chemo-and stereo-selective asymmetric reduction of electronically activated carbon-carbon double bonds [25,27,[60][61][62], as depicted in Scheme 8.…”
Section: Multi-step Reactions Including Ered/bvmo Activity Catalyzed ...mentioning
confidence: 99%
“…Communications cation is likely to extend to TsOYE variants, which have demonstrated broad substrate acceptance, are robust in harsh conditions, and can switch enantioselectivity. [38] We extended this system to two commercially available ene-reductases, ENE-103 and ENE-107 (Johnson Matthey), which are typically sold as a kit with GDH and formate dehydrogenase for NAD(P)H recycling. The alkene reductions demonstrated were dimethyl itaconate (3) reduction to dimethyl (R)-methyl succinate (4) by ENE-103 and 4-phenyl-3-buten-2-one (5) reduction to 4-phenyl-2-butanone (6) by ENE-107 (Table 2), using the same protocols established for TsOYE.…”
Section: Angewandte Chemiementioning
confidence: 99%